...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Current Problems in Cancer >Diagnosis and Management of Classical Hodgkin Lymphoma During the COVID-19 Pandemic
【24h】

Diagnosis and Management of Classical Hodgkin Lymphoma During the COVID-19 Pandemic

机译：

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The coronavirus disease 2019 (COVID-19) pandemic has brought life to a standstill globally. Intermittent quarantines were applied to control the pandemic and reduce contamination. During the pandemic, pa-tients with hematological malignancies were among the most vulnerable population. Our aim was to com-pare in terms of demographic data, disease-related factors, symptom-to-diagnosis interval, diagnosis-to -treatment interval , and interim and end-of-treatment response in classical Hodgkin lymphoma patients diagnosed during the pandemic and in the pre-pandemic periods. A total of 90 patients were included, of which 65 and 25 were diagnosed in the 2 years before the pandemic and the 12-month period during the pandemic, respectively. Demographic features were comparable in both groups. Although the percentage of patients with advanced-stage disease was higher during the pandemic (64 vs 53.8), this difference did not reach statistical significance ( P = 0.384). The median symptom-to-diagnosis interval was significantly longer during the pandemic than was observed within the pre-pandemic era (16 weeks vs 8 weeks, P = 0.042). The median diagnosis-to-treatment intervals was similar in both groups (13 days vs 15 days, P = 0.253). In the pre-pandemic and pandemic periods, 85.2 and 72.7 of the patients had complete response at end-of-treatment evaluation, respectively ( P = 0.208). We found that symptom-to-diagnosis interval was significantly prolonged during the pandemic. Higher percentage of patients with advanced-stage disease during the pandemic might also be due to this delay, nevertheless, this difference did not reach to a sig-nificant difference regarding treatment response in both groups.(c) 2022 Elsevier Inc. All rights reserved.

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号